Roberta Muni (@roberta_muni) profile picture

Radiation Oncologist ASST Papa Giovanni XXIII, Neurooncology, Hematological Malignancies, Radiosurgery, Total Body Irradiation

Bergamo, Lombardy
Joined October 2021
Photo by Roberta Muni (@roberta_muni)Photo by Roberta Muni (@roberta_muni)Photo by Roberta Muni (@roberta_muni)Photo by Roberta Muni (@roberta_muni)
🧠 New paper in Neuro-Oncology 📄 Epigenetic evolution of IDH-wildtype glioblastomas MGMT promoter status is stable in ~93% of cases from diagnosis to recurrence. ➡️ MGMT at diagnosis usually remains clinically valid at recurrence. academic.oup.com/neuro-oncol… #Glioblastoma #MGMT
1
7
1,287
Must read: ESTRO-ISRS clinical practice recommendations for re-irradiation of spinal metastases with Stereotactic Body Radiotherapy: Delphi consensus supported by a systematic review and meta-analysis sciencedirect.com/science/ar…
1
10
22
1,487
Fantastic talk by Martin van de Bent on the long-term results of @EORTC CATNON trial at @EANOassociation #2025Prague. soon on @TheLancetOncol - Adjuv TMZ (no concurrent) provides meaningful OS results. - With a m OS of about 12 y, 45% G3 IDH-mut astro pts are still alive.
4
26
602
This study found that #nilotinib was safe but had limited activity in biomarker-selected recurrent #HGGs. A few patients had exceptional responses, underscoring the need to better understand glioma genomic aberrations & their influence on targeted therapy bit.ly/4qlLKSK
2
2
5
271
The evidence-based safety statements developed during this @myESMO @ESTRO_RT project, provide practical guidance on combining RT with targeted cancer therapies and immunotherapy.
💫🌟🚨 Ann Oncol ESMO–ESTRO Consensus Safety of combining RT with systemic therapies Authors: @GPentheroudaki @umbertoricardi @gminniti2012 @DrAngelaLamarca @OncoAlert 🔑 Key messages: 🔵 ICI + RT: Feasible in selected scenarios, but monitor for ↑risk pneumonitis & late toxicities 🟢 VEGF(R)-inhibitors + RT: Careful with bleeding & wound healing complications 🟡 TKIs + RT: Drug–RT interactions may exacerbate toxicity; dose/timing adjustments essential 🟣 Evidence gaps remain → strong call for multidisciplinary decision-making 🔴 Practical guidance for safe integration in clinical trials & practice 👥 @myESMO @ESTRO_org  @ASCO #RadOnc #Immunotherapy #TargetedTherapy #OncoTwitter #ESMO annalsofoncology.org/article…
1
1
8
1,408
Congrats to the @ISRSy guideline committee on this fantastic guideline on the management of cavernous sinus hemangioma with SRS @IJROBP. Radiation, be it SRS or fractionated radiotherapy, is the standard of care achieving sustained long term local control. pubmed.ncbi.nlm.nih.gov/4081…
28
1
68
3,527
Roberta Muni retweeted
New in #practicalRO: Postoperative Stereotactic Radiosurgery for Resected Brain Metastases: Targeting of the Surgical Tract. #radonc tinyurl.com/prorivers
1
20
2
46
10,007
This is a big unanswered question. Do you contour the surgical tract? I don't do and I have seen very few progression (<3%) @SapienzaRoma
New in #practicalRO: Postoperative Stereotactic Radiosurgery for Resected Brain Metastases: Targeting of the Surgical Tract. #radonc tinyurl.com/prorivers
5
12
44
4,325
So proud to share mid-term results of our POPART trial on prostate bed SBRT — core of my thesis and a project I deeply believe in ✨ Alongside #SCIMITAR & #SHORTER, another step towards the 5fx revolution! 💥 Forever🙏🏼@StAr_MCM74 50days free access⬇️ authors.elsevier.com/c/1lYbQ…
9
27
3
84
10,373
Volumetric assessment should be considered for most brain tumors: Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2-3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trial academic.oup.com/noa/article… @EORTC @EANOassociation
8
24
1,631
must read.. neurocognitive impact of brain treatments are one of the most important topic in our field. Putting many efforts on that with great research groups at @SapienzaRoma @NeuromedIRCCS @UPMC Roma FBF
Saviola et al. @FrancescaSavio9 @SSarubbo showed that presurgical dynamic properties of executive networks, especially fronto-parietal network, can predict short-term attention deficits and recovery after glioma resection. #JNO Read more:link.springer.com/article/10…
1
1
12
834
Roberta Muni retweeted
New in #practicalRO: Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice Guideline. #radonc tinyurl.com/probovi
1
16
2
39
4,724
Shifting away from elective nodal irradiation in HNSCC: What do we know and where are we heading? Kudos to Julien Biau for leading this. @PBlanchardMD @sueyom @joncaci @RO_GreenJournal sciencedirect.com/science/ar…
11
18
1,588
Implementation and dissemination in Radiation Oncology. Do you agree with us? sciencedirect.com/science/ar…
16
Another dogma is disappearing: SRS is effective for SCLC BM. Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JCO…
2
19
41
2,329
Antiseizure medications, surgery, CHT, and RT contribute to controlling seizures in a multidisciplinary approach Tumor‐related epilepsy in glioma: A multidisciplinary overview - Michelucci - Epilepsia - Wiley Online Library onlinelibrary.wiley.com/doi/… @SapienzaRoma
2
8
466
Happy to see these data presented at ASCO2025 now in JCO. I am not surprised. We use this approach in most of our patients who are on systemic therapy. I don't see the reason to target 1200 ml of normal brain with WBRT vs small cc cumulative tumor with SRS
4
22
1,417
must read..
Multi-Institutional Atlas of Brain Metastases Informs Spatial Modeling for Precision Imaging and Personalized Therapy, published in Nature Communications. 👉 Read it before your patients: bit.ly/45Kmca1 @NatureComms
3
12
690